Cumberland Pharmaceuticals Inc. Proceeds from Long-Term Debt Issued
Cumberland Pharmaceuticals Inc. (CPIX) reported Proceeds from Long-Term Debt Issued of $18.00 million for the 12-month period ending 2009-12-31, per its 10-K filed 2012-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2012-03-07
- Cumberland Pharmaceuticals Inc. proceeds from issuance of long-term debt for fiscal 2009 was $18.00M.
| Period end | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|
| 2009-12-31 | $18.00M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |